Cargando…

Inhaled Pharmacotherapy and Stroke Risk in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Study Using Two-Stage Approach

BACKGROUND AND PURPOSE: Patients with chronic obstructive pulmonary disease (COPD) are at higher risk of stroke than those without COPD. This study aims to explore the impact of inhaled pharmacotherapy on stroke risk in COPD patients during a three-year follow-up, using a nationwide, population-base...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Hui-Wen, Chung, Chi-Li, Lin, You Shuei, Yu, Chia-Ming, Lee, Chun-Nin, Bien, Mauo-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497597/ https://www.ncbi.nlm.nih.gov/pubmed/26158649 http://dx.doi.org/10.1371/journal.pone.0130102

Ejemplares similares

Chronic obstructive pulmonary disease with short-acting inhaled pharmacotherapy increases the risk of prostate cancer: A two-stage database approach
por: Lin, Hui-Wen, et al.
Publicado: (2018)

Pharmacotherapy of chronic obstructive pulmonary disease: Therapeutic considerations with a focus on inhaled corticosteroids
por: Irusen, Elvis M., et al.
Publicado: (2020)

Inhaled Corticosteroids Increase the Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study
por: Lee, Ming-Chia, et al.
Publicado: (2015)

VEGF Correlates with Inflammation and Fibrosis in Tuberculous Pleural Effusion
por: Bien, Mauo-Ying, et al.
Publicado: (2015)

Evaluating the association of osteoporosis with inhaled corticosteroid use in chronic obstructive pulmonary disease in Taiwan
por: Chiu, Kai-Lin, et al.
Publicado: (2021)

Inhaled Pharmacotherapy for Neonates: A Narrative Review
por: Rocha, Gustavo
Publicado: (2022)

Risk of Stroke and Post-Stroke Adverse Events in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease
por: Lin, Chao-Shun, et al.
Publicado: (2017)

Diabetes risks and outcomes in chronic obstructive pulmonary disease patients: Two nationwide population-based retrospective cohort studies
por: Lin, Chao-Shun, et al.
Publicado: (2017)

Diagnosis and Pharmacotherapy of Stable Chronic Obstructive Pulmonary Disease: The Finnish Guidelines
por: Kankaanranta, Hannu, et al.
Publicado: (2015)

Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important
por: Mahler, Donald A., et al.
Publicado: (2020)

Cigarette smoke is a risk factor for severity and treatment outcome in patients with culture-positive tuberculosis
por: Chuang, Hsiao-Chi, et al.
Publicado: (2015)

Gender Differences in Inhaled Pharmacotherapy Utilization in Patients with Obstructive Airway Diseases (OADs): A Population-Based Study
por: Amegadzie, Joseph Emil, et al.
Publicado: (2020)

Inhalation devices and inhaled corticosteroids particle size influence on severe pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort study
por: Heerfordt, Christian Kjer, et al.
Publicado: (2023)

Influenza Vaccination and Risk of Stroke in Women With Chronic Obstructive Pulmonary Disease: A Nationwide, Population-Based, Propensity-Matched Cohort Study
por: Chen, Chun-Chao, et al.
Publicado: (2022)

Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis
por: Mills, Edward J, et al.
Publicado: (2011)

Pharmacotherapy for pulmonary arterial hypertension
por: Burki, Talha Khan
Publicado: (2020)

Chinese Herbal Medicine (Weijing Decoction) Combined with Pharmacotherapy for the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Liu, Shaonan, et al.
Publicado: (2014)

Inhaled Corticosteroids Increase the Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study: Erratum
Publicado: (2017)

CXCL12 Induces Connective Tissue Growth Factor Expression in Human Lung Fibroblasts through the Rac1/ERK, JNK, and AP-1 Pathways
por: Lin, Chien-Huang, et al.
Publicado: (2014)

Association of chronic obstructive pulmonary disease and hemorrhoids: A nationwide cohort study
por: Lin, Lih-Hwa, et al.
Publicado: (2017)

Inhaled Corticosteroids and the Risk of Nontuberculous Mycobacterial Pulmonary Disease in Chronic Obstructive Pulmonary Disease: Findings from a Nationwide Population-Based Study
por: Yu, Iseul, et al.
Publicado: (2023)

Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2018)

Treatment with inhaled corticosteroids in chronic obstructive pulmonary disease
por: Janson, Christer
Publicado: (2020)

The future of inhalation therapy in chronic obstructive pulmonary disease
por: Cazzola, Mario, et al.
Publicado: (2022)

Risk of Periodontal Diseases in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Population-based Cohort Study
por: Shen, Te-Chun, et al.
Publicado: (2015)

Optimizing inhalation therapy in the aspect of peak inhalation flow rate in patients with chronic obstructive pulmonary disease or asthma
por: Hua, Jian-lan, et al.
Publicado: (2021)

Comparing Randomized Controlled Trials and Real-World Studies in Chronic Obstructive Pulmonary Disease Pharmacotherapy
por: Tashkin, Donald P, et al.
Publicado: (2020)

Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review
por: Celli, Bartolome R., et al.
Publicado: (2021)

Characteristics of length of stay and cardiovascular pharmacotherapy advice among chronic obstructive pulmonary disease patients
por: Fang, Hang, et al.
Publicado: (2021)

Association between chronic obstructive pulmonary disease and ventricular arrhythmia: a nationwide population-based cohort study
por: Chen, Chun-Chao, et al.
Publicado: (2021)

Fluoroquinolones versus β-Lactam/β-Lactamase Inhibitors in Outpatients with Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based Study
por: Lin, Kuan-Yin, et al.
Publicado: (2015)

Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population
por: Tsai, Ming-Jun, et al.
Publicado: (2015)

An evaluation of the use of inhalers in asthma and chronic obstructive pulmonary disease
por: Çakmaklı, Seçil, et al.
Publicado: (2023)

The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease
por: Park, Ji Won, et al.
Publicado: (2023)

Relationship Between Changes in Inhalation Treatment Level and Exacerbation of Chronic Obstructive Pulmonary Disease: Nationwide the Health Insurance and Assessment Service Database
por: Jo, Yong Suk, et al.
Publicado: (2020)

Trend, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit/hyperactivity disorder: a nationwide survey in Taiwan
por: Cheng, Yu-Shian, et al.
Publicado: (2017)

Stroke risk and outcomes in patients with chronic kidney disease or end-stage renal disease: Two nationwide studies
por: Cherng, Yih-Giun, et al.
Publicado: (2018)

New-Onset Atrial Fibrillation Is a Risk Factor of Ischemic Stroke in Chronic Obstructive Pulmonary Disease
por: Liu, Chi-Chun, et al.
Publicado: (2022)

Reply to Mahler et al.: Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important
por: Nici, Linda, et al.
Publicado: (2020)

Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat(®) Soft Mist(™) Inhaler
por: Hodder, Richard, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_qg8vtv3mv33bnf0hr0bsf1rrqe